Immunobacteriological aspects of pyelonephritis.
D000818:Animals; D000942:Antigens, Bacterial; D001402:B-Lymphocytes / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000276:immunology*; D007111:Immunity, Cellular; D007074:Immunoglobulin G / Q000096:biosynthesis; D007668:Kidney / Q000276:immunology*; D008211:Lymphocyte Cooperation; D011704:Pyelonephritis / Q000188:drug therapy / Q000276:immunology*; D051381:Rats; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000942:Antigens, Bacterial; D007074:Immunoglobulin G; D003520:Cyclophosphamide